Leslie L. Popplewell, MD
Medical Director of Hematology and Blood and Marrow Transplant, City of Hope Cancer Center Atlanta
CAR T-Cell Therapy offers new hope for people with relapsed or refractory non-Hodgkin lymphoma. Learn what Atlanta-area patients can expect — from T-cell collection and infusion to side effects, recovery, and follow-up care at leading centers like City of Hope.
Leslie L. Popplewell, MD
City of Hope Cancer Center Atlanta
CAR T-cell therapy has changed the outlook for relapsed or refractory lymphoma, yet many eligible patients in the U.S., including Georgia, still don’t receive it. Learn why this life-saving treatment remains underused and how Atlanta-area patients can overcome barriers to access care at leading centers.
Dr Leslie Popplewell
City of Hope Cancer Center Atlanta
If you or a loved one is facing recurrent large B-cell lymphoma in the Atlanta area, the history of CAR T-Cell Therapy matters for more than just context—it matters for your decisions, your timeline, and your access. You’re not limited to options of a decade ago. You’re in a region where advanced immunotherapies are real, available, and supported locally.
